Product Information
HUMULIN 70-30 VIAL is a brand product labeled by Eli Lilly and Company, priced at $4.2597 per ML under NDC 00002871501. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
100 [iU]/mL
Manufacturer
Eli Lilly and CompanyNDC
00002871501
Classification
Brand
Dosage Form
INJECTION, SUSPENSION
Route
SUBCUTANEOUS
Last Updated
6/17/2026
Active Ingredients
INSULIN HUMANApproval Type
Biologic (BLA)
FDA Application
BLA019717On Market Since
6/26/1989
Pharmacological Classes
Price Statistics
The NADAC for HUMULIN 70-30 VIAL has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 47.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.2597 per ML |
|---|---|
| All-time high | $14.6189 (Jan 16, 2019) |
| All-time low | $4.2597 (Jun 17, 2026) |
| 52-week high | $4.2707 |
| 52-week low | $4.2597 |
| Median price | $14.2821 |
| Average price | $11.5864 |
| Largest weekly change | -70.0% (Jan 10, 2024) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of HUMULIN 70-30 VIAL?
The current National Average Drug Acquisition Cost (NADAC) for HUMULIN 70-30 VIAL, manufactured by Eli Lilly and Company, is $4.2597 per ML (NDC 00002871501), effective Jun 24, 2026.
How has the price of HUMULIN 70-30 VIAL changed over time?
Over the history we have for it, the NADAC for HUMULIN 70-30 VIAL has declined 47.2%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for HUMULIN 70-30 VIAL?
Since Nov 28, 2013, the NADAC for HUMULIN 70-30 VIAL has ranged from a low of $4.2597 (Jun 17, 2026) to a high of $14.6189 (Jan 16, 2019), with a median of $14.2821 per ML.
Are there cheaper alternatives to HUMULIN 70-30 VIAL?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as HUMULIN 70-30 VIAL, but none are currently priced below it.
Who manufactures HUMULIN 70-30 VIAL?
HUMULIN 70-30 VIAL (NDC 00002871501) is labeled by Eli Lilly and Company, and CMS classifies it as a brand product.
Related Drugs
Same classification